Nanoparticles as immunomodulators and translational agents in brain tumors.

Adam J GrippinKyle A DysonSadeem QdaisatJames McGuinessBrandon WummerDuane A MitchellHector R Mendez-GomezElias J Sayour

Published in: Journal of neuro-oncology (2020)

Review of early preclinical studies and clinical trials provides foundational safety, feasibility and toxicology data that can usher a new wave of nanotherapeutics in application of immunotherapy and translational oncology for patients with brain tumors.

Keyphrases

clinical trial
palliative care
electronic health record
big data
case control
phase ii
randomized controlled trial
machine learning
deep learning